Myasthenia gravis
Anti-acetylcholine-receptor antibodies at the NMJ (post-synaptic)
Overview
An autoimmune disorder of the neuromuscular junction (antibodies against the post-synaptic acetylcholine receptor) causing FATIGABLE muscle weakness — worse with use and at the end of the day. Ocular and bulbar muscles are typically affected; the emergency is a myasthenic (respiratory) crisis. Associated with thymoma.
Recognise
- FATIGABLE weakness: ptosis, diplopia, dysphagia, dysarthria, proximal limb weakness — worse with use/evening
- Improves with rest; normal reflexes and sensation
- Associated thymoma/thymic hyperplasia; younger women, older men
Red flags
- Myasthenic CRISIS — respiratory muscle weakness (monitor FVC), bulbar weakness with aspiration; certain drugs trigger it
Differentials & how to tell them apart
Investigations
Anti-AChR antibodies (90%; anti-MuSK if negative); single-fibre EMG / repetitive nerve stimulation (decrement); CT thorax for THYMOMA; serial FVC in crisis.
Management
Pyridostigmine (+ immunosuppression); crisis: IVIG/plasma exchange + ventilatory support
- 1Pyridostigmine for symptoms; add corticosteroids + steroid-sparing immunosuppression (azathioprine) for disease control; CT thorax for thymoma (→ thymectomy).Gate: Myasthenic CRISIS (respiratory weakness) → monitor FVC, treat with IVIG or plasma exchange + ventilatory support; AVOID drugs that worsen MG (aminoglycosides, macrolides, quinolones, beta-blockers)
- 2Thymectomy if thymoma or selected AChR-positive disease; pregnancy and drug-precaution counselling.
Key points
Fatigable weakness worse with use = myasthenia (anti-AChR); weakness that IMPROVES with use + reduced reflexes + lung cancer = Lambert-Eaton. Always check a CT thorax for thymoma. FVC, not sats, tracks crisis.
Monitor & prognosis
FVC in crisis, symptom fatigability, antibody/EMG, thymus imaging, drug interactions.
Good with treatment; crises are the acute danger.
Source: NICE CKS; Association of British Neurologists